| Product Code: ETC7550335 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India partial androgen insensitivity syndrome market import shipments experienced a notable CAGR of 7.7% from 2020 to 2024, indicating steady expansion. Particularly impressive was the robust growth rate of 55.0% between 2023 and 2024, showcasing an accelerating momentum in market demand during that period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Partial Androgen Insensitivity Syndrome Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Partial Androgen Insensitivity Syndrome Market Revenues & Volume, 2021 & 2031F |
3.3 India Partial Androgen Insensitivity Syndrome Market - Industry Life Cycle |
3.4 India Partial Androgen Insensitivity Syndrome Market - Porter's Five Forces |
3.5 India Partial Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 India Partial Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.7 India Partial Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 India Partial Androgen Insensitivity Syndrome Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Partial Androgen Insensitivity Syndrome Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and education about partial androgen insensitivity syndrome (PAIS) in India |
4.2.2 Advances in medical technology and genetic testing for early diagnosis of PAIS |
4.2.3 Growing healthcare infrastructure and access to specialized healthcare services for PAIS patients in India |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare providers for PAIS management in India |
4.3.2 Stigma and social taboos associated with intersex conditions like PAIS in Indian society |
4.3.3 Affordability and accessibility issues related to expensive treatments and medications for PAIS in India |
5 India Partial Androgen Insensitivity Syndrome Market Trends |
6 India Partial Androgen Insensitivity Syndrome Market, By Types |
6.1 India Partial Androgen Insensitivity Syndrome Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 India Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 India Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Surgery, 2021- 2031F |
6.1.4 India Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Estrogen or Testosterone Therapy, 2021- 2031F |
6.1.5 India Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Partial Androgen Insensitivity Syndrome Market, By Mode of Administration |
6.2.1 Overview and Analysis |
6.2.2 India Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Injectables, 2021- 2031F |
6.2.3 India Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.4 India Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Partial Androgen Insensitivity Syndrome Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 India Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 India Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 India Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.4 India Partial Androgen Insensitivity Syndrome Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 India Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 India Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 India Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 India Partial Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
7 India Partial Androgen Insensitivity Syndrome Market Import-Export Trade Statistics |
7.1 India Partial Androgen Insensitivity Syndrome Market Export to Major Countries |
7.2 India Partial Androgen Insensitivity Syndrome Market Imports from Major Countries |
8 India Partial Androgen Insensitivity Syndrome Market Key Performance Indicators |
8.1 Average age of diagnosis for PAIS patients in India |
8.2 Number of healthcare facilities offering specialized care for PAIS in India |
8.3 Rate of successful treatment outcomes for PAIS patients in India |
9 India Partial Androgen Insensitivity Syndrome Market - Opportunity Assessment |
9.1 India Partial Androgen Insensitivity Syndrome Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 India Partial Androgen Insensitivity Syndrome Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.3 India Partial Androgen Insensitivity Syndrome Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 India Partial Androgen Insensitivity Syndrome Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Partial Androgen Insensitivity Syndrome Market - Competitive Landscape |
10.1 India Partial Androgen Insensitivity Syndrome Market Revenue Share, By Companies, 2024 |
10.2 India Partial Androgen Insensitivity Syndrome Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here